Back to GetFilings.com



 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

FORM 10-Q

 

(Mark One)

 

 

ý

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

For the quarterly period ended June 30, 2004.

 

 

OR

 

 

o

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

For the transition period from                                  to                                  .

 

 

Commission File Number:  0-21184

 

MICROCHIP TECHNOLOGY INCORPORATED

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware

 

86-0629024

(State or Other Jurisdiction of
Incorporation or Organization)

 

(IRS Employer
Identification No.)

 

 

 

2355 W. Chandler Blvd., Chandler, AZ 85224-6199
(480) 792-7200

(Address, Including Zip Code, and Telephone Number,
Including Area Code, of Registrant’s
Principal Executive Offices)

 

Indicate by checkmark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to the filing requirements for the past 90 days.

 

Yes   ý     No   o

 

Indicate by checkmark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Securities Exchange Act of 1934).

 

Yes   ý     No   o

 

Number of shares of common stock, $.001 par value, outstanding as of July 30, 2004: 205,865,693 shares.

 

 



 

MICROCHIP TECHNOLOGY INCORPORATED AND SUBSIDIARIES

 

INDEX

 

PART I.

FINANCIAL INFORMATION

 

 

 

 

 

Item 1.

Financial Statements (Unaudited)

 

 

 

 

 

 

 

 

Condensed Consolidated Balance Sheets -

 

 

 

 

June 30, 2004 and March 31, 2004

 

 

 

 

 

 

 

 

Condensed Consolidated Statements of Income -

 

 

 

 

Three Months Ended June 30, 2004 and June 30, 2003

 

 

 

 

 

 

 

 

Condensed Consolidated Statements of Cash Flows -

 

 

 

 

Three Months Ended June 30, 2004

 

 

 

 

 

 

 

 

Notes to Condensed Consolidated Financial Statements

 

 

 

 

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

 

 

 

 

 

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

 

 

 

 

 

 

Item 4.

Controls and Procedures

 

 

 

 

 

PART II.

OTHER INFORMATION

 

 

 

 

 

 

Item 1.

Legal Proceedings

 

 

 

 

 

 

Item 2.

Changes in Securities, Use of Proceeds and Issuer Purchases of Equity Securities

 

 

 

 

 

 

Item 6.

Exhibits and Reports on Form 8-K

 

 

 

 

 

SIGNATURES

 

 

 

 

 

CERTIFICATIONS

 

 

 

 

 

EXHIBITS

 

 

2



 

MICROCHIP TECHNOLOGY INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

 

(in thousands, except share amounts)

 

 

 

June 30
2004

 

March 31
2004

 

 

 

(Unaudited)

 

(Note 1)

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

86,886

 

$

105,334

 

Short-term investments

 

451,978

 

369,216

 

Accounts receivable, net

 

112,519

 

109,231

 

Inventories

 

90,575

 

94,514

 

Prepaid expenses

 

6,306

 

6,884

 

Deferred tax assets

 

101,297

 

126,046

 

Other current assets

 

72,274

 

72,720

 

Total current assets

 

921,835

 

883,945

 

 

 

 

 

 

 

Property, plant and equipment, net

 

673,576

 

689,206

 

Goodwill

 

32,346

 

32,346

 

Intangible assets, net

 

9,327

 

9,698

 

Other assets

 

7,625

 

6,948

 

 

 

 

 

 

 

Total assets

 

$

1,644,709

 

$

1,622,143

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

Accounts payable

 

$

37,759

 

$

61,184

 

Accrued liabilities

 

130,305

 

124,051

 

Deferred income on shipments to distributors

 

93,632

 

84,816

 

Total current liabilities

 

261,696

 

270,051

 

 

 

 

 

 

 

Pension accrual

 

792

 

871

 

Deferred tax liability

 

27,092

 

30,704

 

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

 

 

 

 

 

 

Preferred stock, $.001 par value; authorized 5,000,000 shares; no shares issued or outstanding.

 

 

 

Common stock, $.001 par value; authorized 450,000,000 shares; issued 208,556,546 and outstanding 207,073,600 shares at June 30, 2004; issued 208,556,546 and outstanding 206,589,038 shares at March 31, 2004.

 

207

 

207

 

Additional paid-in capital

 

551,220

 

558,354

 

Accumulated other comprehensive income (loss)

 

(5,760

)

733

 

Retained earnings

 

848,840

 

813,307

 

Less shares of common stock held in treasury at cost; 1,482,946 shares at June 30, 2004 and 1,967,508 shares at March 31, 2004.

 

(39,378

)

(52,084

)

Net stockholders’ equity

 

1,355,129

 

1,320,517

 

 

 

 

 

 

 

Total liabilities and stockholders’ equity

 

$

1,644,709

 

$

1,622,143

 

 

See accompanying notes to condensed consolidated financial statements

 

3



 

MICROCHIP TECHNOLOGY INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

 

(in thousands, except per share amounts)

(Unaudited)

 

 

 

Three Month Ended June 30,

 

 

 

2004

 

2003

 

 

 

 

 

 

 

Net sales

 

$

212,775

 

$

161,283

 

Cost of sales

 

91,316

 

105,762

 

Gross profit

 

121,459

 

55,521